Ignite Creation Date:
2024-05-05 @ 11:48 PM
Last Modification Date:
2024-10-26 @ 10:40 AM
Study NCT ID:
NCT01425749
Status:
COMPLETED
Last Update Posted:
2016-04-04
First Post:
2011-07-19
Brief Title:
Study to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCI
Sponsor:
Craig L Slingluff Jr
Organization:
University of Virginia
Organization Data
Organization:
University of Virginia
Class:
OTHER
Study ID:
CSlingluff
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Craig L Slingluff Jr
Lead Sponsor Class:
OTHER
Responsible Party:
Craig L Slingluff Jr
Responsible Party Title:
Professor of Surgery Director Human Immune Therapy Center
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
University of Virginia
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| GlaxoSmithKline | INDUSTRY |